Skip links
Companies
› United States › SEMNUR PHARMACEUTICALS, INC.
SEMNUR PHARMACEUTICALS, INC. logo

SEMNUR PHARMACEUTICALS, INC.

Active

in

Registration No.
3576313
Incorporation Date
2013-06-07
Company Type
Not disclosed
Address
PALO ALTO, United States
Website
www.semnurpharma.com/
Source: California Secretary of State — bizfile Online

SEMNUR PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 3576313, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 7 June 2013 and lists its registered address as PALO ALTO, United States. 2 shareholders are on record for SEMNUR PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 5 October 2026.

Data Provenance
This record is sourced directly from official government registries, including California Secretary of State — bizfile Online.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

2

Two shareholders are currently on record for SEMNUR PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is RiverNorth Capital Management, LLC, holding 84.9% — a majority holding — followed by Saba Capital Income & Opportunities Fund at 15.1%.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
RiverNorth Capital Management, LLC 84.9% California Secretary of State — bizfile Online
Saba Capital Income & Opportunities Fund 15.1% California Secretary of State — bizfile Online

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Executive Chairperson of SEMNUR PHARMACEUTICALS, INC. currently on record is Henry H. Ji Ph.d.; five officers are currently on record for SEMNUR PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online.

The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at SEMNUR PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

HH
Henry H. Ji Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Chairperson

JS
Jaisim Shah ACTIVE

Residence
🇺🇸 United States
Occupation
Ceo, President & Director

MS
Mahendra Shah ACTIVE

Residence
🇺🇸 United States
Occupation
Agent

SL
Steve Lincoln ACTIVE

Residence
🇺🇸 United States
Occupation
Agent

SM
Stephen Ma ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vp, Cfo & Secretary

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

SEMNUR PHARMACEUTICALS, INC. sits 2 levels below its ultimate parent, Scilex Holding Company, registered in United States. The full chain up to Scilex Holding Company is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by SEMNUR PHARMACEUTICALS, INC.'s own shareholder record.

Ultimate HQ
Scilex Holding Company
United States

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on SEMNUR PHARMACEUTICALS, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns SEMNUR PHARMACEUTICALS, INC.?

Two shareholders are currently on record for SEMNUR PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is RiverNorth Capital Management, LLC, holding 84.9% — a majority holding — followed by Saba Capital Income & Opportunities Fund at 15.1%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is SEMNUR PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for SEMNUR PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does SEMNUR PHARMACEUTICALS, INC. have on record?

2 shareholders are shown on record for SEMNUR PHARMACEUTICALS, INC..

What is SEMNUR PHARMACEUTICALS, INC.'s company registration number?

SEMNUR PHARMACEUTICALS, INC.'s registration number is 3576313, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.

Is SEMNUR PHARMACEUTICALS, INC. still an active company?

SEMNUR PHARMACEUTICALS, INC.'s status on California Secretary of State — bizfile Online is listed as active.

When was SEMNUR PHARMACEUTICALS, INC. incorporated?

SEMNUR PHARMACEUTICALS, INC. was incorporated on 7 June 2013, according to California Secretary of State — bizfile Online.

What is SEMNUR PHARMACEUTICALS, INC.'s registered address?

The registered address on file for SEMNUR PHARMACEUTICALS, INC. is PALO ALTO, United States.

Who are the officers/directors of SEMNUR PHARMACEUTICALS, INC.?

The Executive Chairperson of SEMNUR PHARMACEUTICALS, INC. currently on record is Henry H. Ji Ph.d.; five officers are currently on record for SEMNUR PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online. Management authority at SEMNUR PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does SEMNUR PHARMACEUTICALS, INC. have a parent company or subsidiaries?

SEMNUR PHARMACEUTICALS, INC. sits 2 levels below its ultimate parent, Scilex Holding Company, registered in United States.

Can Zavia monitor changes to SEMNUR PHARMACEUTICALS, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to SEMNUR PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access SEMNUR PHARMACEUTICALS, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like SEMNUR PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 5 October 2026.

This website uses cookies to improve your web experience.